Altamofen

Tamoxifen Citrate 20mg

What is Altamofen (Tamoxifen Citrate) 20mg?

Altamofen is a pharmaceutical product containing Tamoxifen Citrate as its active ingredient, with each tablet providing a concentration of 20mg. Tamoxifen Citrate is classified as a selective estrogen receptor modulator (SERM) and is widely used in the treatment of certain breast cancer conditions.

Indications:

Altamofen is specifically indicated for the treatment of axillary node-negative breast cancer in women following total mastectomy or segmental mastectomy, accompanied by axillary dissection and breast irradiation. The following elaborates on the key indications for Altamofen:

1. Axillary Node-Negative Breast Cancer: Altamofen is primarily employed in the treatment of breast cancer cases where the cancer has not spread to the axillary (armpit) lymph nodes. This application is significant for a specific subset of breast cancer patients.

2. Post-Mastectomy Treatment: Altamofen is recommended for women who have undergone either total mastectomy (complete removal of the breast) or segmental mastectomy (partial removal of the breast) as part of their breast cancer treatment.

3. Axillary Dissection: Altamofen is part of the therapeutic approach following axillary dissection, a surgical procedure involving the removal of lymph nodes from the armpit region. This is a crucial step in breast cancer management.

4. Breast Irradiation: The treatment plan includes breast irradiation, which involves the use of radiation to target and destroy cancer cells in the affected breast tissue. Altamofen complements this aspect of the therapeutic strategy.

How Does it Work?

Tamoxifen Citrate, the active ingredient in Altamofen, functions as a selective estrogen receptor modulator. It competitively binds to estrogen receptors in breast tissues, inhibiting the action of endogenous estrogen. In estrogen receptor-positive breast cancers, where estrogen promotes the growth of cancer cells, Tamoxifen disrupts this stimulation. By acting as an antagonist to estrogen in breast tissue, Tamoxifen helps prevent further growth and proliferation of cancer cells.

Dosage and Administration:

Healthcare professionals determine the appropriate dosage and administration schedule for Altamofen based on individual patient characteristics, the specific breast cancer condition, and the overall treatment plan. Patients are typically advised to take the prescribed dose orally, with or without food, as directed by their healthcare provider.

Onset of Action:

The onset of action of Altamofen may vary among individuals. Patients are advised to adhere to the prescribed treatment schedule to maximize the therapeutic benefits.

Duration of Treatment:

The duration of Altamofen treatment is determined by the healthcare provider based on individual response to therapy, overall treatment goals, and ongoing assessment of the patient's condition.

Monitoring and Follow-Up:

Regular medical monitoring and follow-up appointments are essential during Altamofen treatment. Healthcare providers assess treatment efficacy, monitor potential side effects, and make any necessary adjustments to the treatment plan.

Presentation

Each carton contains 50 tablets of 20mg each.